BIOTEM First Class Antibodies & Immunoassays
Created in 1980
Social networks
424 3,499Activities
Technologies
Entity types
Location
885 Rue Alphonse Gourju, 38140 Apprieu, France
Apprieu
France
Employees
Scale: 11-50
Estimated: 44
SIREN
320508047Engaged corporates
14
3 12Added in Motherbase
3 years, 2 months ago
biotech Value proposition
Your partner in immunotechnologies since 1980!
Our commitment makes the difference!
Expert in immunotechnology, BIOTEM is a contract Research Organisation which complies with ISO 9001:2008 quality standards.
Since its establishment in 1980, the company has been the privileged partner of prestigious industrial and academic laboratories for their R&D, diagnostic and therapeutic projects.
Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project and is pledged to achieve the results outlined in the contract.
BIOTEM advantages:
- Results guaranteed
- An unparalleled traceability throughout your project
- Optimal quality of your product
- Ownership of results
- A policy built around a strict confidentiality
...
=> Services offered by an European leading company in the field of custom antibodies
Please feel free to visit our website for more information www.biotem-antibody.com or info@biotem.fr
Human Monoclonal Antibodies, Murine Monoclonal Antibodies, Immuno Assays, Antibody Production, Custom Antibodies, Immunotechnology, Lateral Flow, Hybridoma, ELISA, Therapeutic Antibodies, Rabbit Monoclonal Antibodies, Polyclonal Antibodies, Antibody Humanization, Phage Display, Recombinant Antibody, In vitro diagnostics, Research, Immunotherapy, and IVD Medical DeviceOriginal language
Your partner in immunotechnologies since 1980!
Our commitment makes the difference!
BIOTEM is a long-established and globally recognized CRO specialized in the generation, engineering and production of novel and unique antibodies as well as a variety of recombinant binders (original scaffolds). This activity of discovery at the service of its clients has been in the DNA of its management and employees since the inception of the activity in the early eighties.
The company also excels in the development and production of finely tuned immunoassays, especially ELISAs and Lateral Flow Rapid Tests (LFIAs). When it comes to the production of such immunoassays, BIOTEM is now also become a CMO, including in the IVDMD domain, offering its clients a complete continuum from raw research to commercialization.
✔ 40+ years of experience
✔ Exclusive technologies
✔ Quality System (ISO 9001 & ISO 13485)
✔ CIR accreditation
🔬 MONOCLONAL & POLYCLONAL ANTIBODIES
> Mouse MAbs – Hybridomas, including exclusive technologies: R.A.D®, S.S.I, Genetic, etc.
> Polyclonal Antibodies – Custom Protocols
> Antibody Conjugation / Modification
> Antibody Production (large scale)
> Antibody Sequencing & Characterization
🧬 RECOMBINANT ANTIBODY & ENGINEERING
> Rabbit MAbs – Via Phage Display – High affinity / adapted for small molecules and novel epitopes
> Llama MAbs – Via Phage Display – VHH antibody production
> Ultimate Humanization® – Antibodies developed in macaque, humanized in a gentle, easy way, with optimized tolerance in humans
> Humanization of antibodies – chimerization and CDR grafting from rodent-developed parent antibodies
> Affinity Maturation, Antibody Sequencing & Characterization
> Recombinant Antibody Production (large scale)
💡 DIAGNOSTICS & IMMUNOASSAYS
> Companion Dx Antibodies – Dreadfully effective for paraffin-embedded tissue sections IHC tests with the IHC Peptide Profiler®
> Lateral Flow & ELISA – Providing medical devices development and associated services in accordance with customer and applicable regulatory requirements
Antibody Production and Immunoassay - Since 1980
Monoclonal and Polyclonal Antibody development and production since 1980, Hybridoma, Phage Display, Antibody Engineering, Immunoassay (ELISA & LFIA), etc.
https://www.biotem-antibody.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 European Commission European Union, Environmental Services | European Commission European Union, Environmental Services | Other 4 Feb 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 18 Nov 2023 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 6 Apr 2023 | | |
 MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Other 3 Jan 2024 | | |
 Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 12 Dec 2023 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 12 Dec 2023 | | |
 Clubster NSL Public business cluster, French Cluster, Civic and Social Organizations | Clubster NSL Public business cluster, French Cluster, Civic and Social Organizations | Other 29 Nov 2022 30 Nov 2022 | | |
 BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 29 Nov 2022 12 Dec 2023 | | |
 Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Other 27 Nov 2020 6 Apr 2023 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 22 Jul 2011 | | |